Details for New Drug Application (NDA): 020759
✉ Email this page to a colleague
The generic ingredient in TROVAN is azithromycin dihydrate; trovafloxacin mesylate. There are thirty-two drug master file entries for this compound. Additional details are available on the azithromycin dihydrate; trovafloxacin mesylate profile page.
Summary for 020759
Tradename: | TROVAN |
Applicant: | Pfizer |
Ingredient: | trovafloxacin mesylate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Dec 18, 1997 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Dec 18, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020759
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-001 | Dec 18, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | TROVAN | trovafloxacin mesylate | TABLET;ORAL | 020759-002 | Dec 18, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription